Empagliflozin Attenuates Renal and Urinary Markers of Tubular Epithelial Cell Injury in Streptozotocin-induced Diabetic Rats

Empagliflozin, a SGLT-2 inhibitor, improves diabetic nephropathy through its pleiotropic anti-inflammatory effects. The present study aims to evaluate empagliflozin effects on renal and urinary levels of tubular epithelial cell injury markers in streptozotocin-induced diabetic rats. Empagliflozin at...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Indian J Clin Biochem
Autors principals: Ashrafi Jigheh, Zahra, Ghorbani Haghjo, Amir, Argani, Hassan, Roshangar, Leila, Rashtchizadeh, Nadereh, Sanajou, Davoud, Nazari Soltan Ahmad, Saeed, Rashedi, Jalil, Dastmalchi, Siavoush, Mesgari Abbasi, Mehran
Format: Artigo
Idioma:Inglês
Publicat: Springer India 2018
Matèries:
Original Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6995469/
https://ncbi.nlm.nih.gov/pubmed/32071503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12291-018-0790-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars